Usana Health Sciences Inc financial data

Symbol
USNA on NYSE
Industry
Medicinal Chemicals & Botanical Products
Location
3838 West Parkway Blvd., Salt Lake City, UT
State of incorporation
UT
Fiscal year end
December 28
Former names
USANA INC (to 4/27/2000)
Latest financial report
10-K - Q4 2024 - Mar 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 333 % -0.38%
Quick Ratio 54.5 % +4.39%
Return On Equity 8.09 % -40%
Return On Assets 6.27 % -40%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.9M shares -0.77%
Common Stock, Shares, Outstanding 19.1M shares -0.35%
Entity Public Float 499M USD -28.6%
Common Stock, Value, Issued 19K USD 0%
Weighted Average Number of Shares Outstanding, Basic 19.1M shares -0.76%
Weighted Average Number of Shares Outstanding, Diluted 19.2M shares -0.95%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 855M USD -7.22%
Operating Income (Loss) 66.3M USD -28.7%
Nonoperating Income (Expense) 10M USD +6.88%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 76.4M USD -25.5%
Income Tax Expense (Benefit) 34.3M USD -11.3%
Net Income (Loss) Attributable to Parent 42M USD -34.1%
Earnings Per Share, Basic 2.2 USD/shares -33.5%
Earnings Per Share, Diluted 2.19 USD/shares -33.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 182M USD -45%
Inventory, Net 69.7M USD +13.5%
Other Assets, Current 4.81M USD -21.1%
Assets, Current 279M USD -33.2%
Deferred Income Tax Assets, Net 19.6M USD +47.9%
Property, Plant and Equipment, Net 94.6M USD -5.26%
Operating Lease, Right-of-Use Asset 21.2M USD +19.8%
Intangible Assets, Net (Excluding Goodwill) 152M USD +407%
Goodwill 144M USD +743%
Other Assets, Noncurrent 58.8M USD +7.13%
Assets 748M USD +18.2%
Accounts Payable, Current 12M USD +19%
Employee-related Liabilities, Current 15.8M USD -2.24%
Accrued Liabilities, Current 13.6M USD +39.2%
Liabilities, Current 140M USD +17.5%
Deferred Income Tax Liabilities, Net 4.07M USD -10.5%
Operating Lease, Liability, Noncurrent 10.2M USD +98.2%
Other Liabilities, Noncurrent 18.2M USD +49.4%
Liabilities 162M USD +19.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -22.7M USD -65.5%
Retained Earnings (Accumulated Deficit) 479M USD +7.58%
Stockholders' Equity Attributable to Parent 532M USD +7.02%
Liabilities and Equity 748M USD +18.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 17.7M USD +37.8%
Net Cash Provided by (Used in) Financing Activities -11.9M USD -273%
Net Cash Provided by (Used in) Investing Activities -4.07M USD -20.4%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 19.1M shares -0.35%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.14M USD -130%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 185M USD -44.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 24K USD +1100%
Deferred Tax Assets, Valuation Allowance 157M USD +14.1%
Deferred Tax Assets, Gross 200M USD +13.3%
Operating Lease, Liability 16.2M USD +30.5%
Payments to Acquire Property, Plant, and Equipment 3.2M USD +51.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 33.1M USD -47.4%
Lessee, Operating Lease, Liability, to be Paid 17.8M USD +38.2%
Property, Plant and Equipment, Gross 212M USD +1.2%
Operating Lease, Liability, Current 6.01M USD -17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.16M USD +7.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.74M USD -11.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.62M USD +237%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.83M USD +115%
Deferred Tax Assets, Operating Loss Carryforwards 2.35M USD +20%
Unrecognized Tax Benefits 1.19M USD +10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.17M USD +1695%
Depreciation, Depletion and Amortization 3.16M USD -4.27%
Deferred Tax Assets, Net of Valuation Allowance 43.5M USD +10.3%
Interest Expense 283K USD +48.2%